Osprey Medical, Inc. Price Chart
Osprey Medical, Inc. OSP.XA Financial and Trading Overview
| Osprey Medical, Inc. stock price | 0.45 AUD |
| Previous Close | 0.46 AUD |
| Open | 0.46 AUD |
| Bid | 0 AUD x N/A |
| Ask | 0.39 AUD x N/A |
| Day's Range | 0.46 - 0.46 AUD |
| 52 Week Range | 0.46 - 0.46 AUD |
| Volume | 6.5K AUD |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | 1.399137 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
OSP.XA Valuation Measures
| Enterprise Value | 6.64M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.1842105 |
| Enterprise Value/Revenue | 3.388 |
| Enterprise Value/EBITDA | -0.546 |
Trading Information
Osprey Medical, Inc. Stock Price History
| Beta (5Y Monthly) | 1.399137 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 0.46 AUD |
| 52 Week Low | 0.46 AUD |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
OSP.XA Share Statistics
| Avg. Volume (3 month) | N/A |
| Avg. Daily Volume (10-Days) | N/A |
| Shares Outstanding | N/A |
| Float | 9.61M |
| Short Ratio | N/A |
| % Held by Insiders | 9.26% |
| % Held by Institutions | 63.26% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | December 31, 2021 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -635.13% |
| Gross Margin | 35.97% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -104.11% |
| Return on Equity (ttm) | -209.65% |
Income Statement
| Revenue (ttm) | 1.96M AUD |
| Revenue Per Share (ttm) | 0.08 AUD |
| Quarterly Revenue Growth (yoy) | 2.39% |
| Gross Profit (ttm) | 705.22K AUD |
| EBITDA | -12159784 AUD |
| Net Income Avi to Common (ttm) | -10046481 AUD |
| Diluted EPS (ttm) | -0.782 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.39M AUD |
| Total Cash Per Share (mrq) | 0.21 AUD |
| Total Debt (mrq) | 225.3K AUD |
| Total Debt/Equity (mrq) | 4.34 AUD |
| Current Ratio (mrq) | 3.559 |
| Book Value Per Share (mrq) | 0.38 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -11664845 AUD |
| Levered Free Cash Flow (ttm) | -6994665 AUD |
Profile of Osprey Medical, Inc.
| Country | Australia |
| State | MN |
| City | Minnetonka |
| Address | 5600 Rowland Road |
| ZIP | 55343 |
| Phone | 952 955 8230 |
| Website | https://ospreymed.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Osprey Medical, Inc., a commercial stage company, provides contrast reduction and monitoring technologies in the United States and internationally. It offers DyeVert Plus EZ and DyeVert Power XT, and DyeVert Plus Systems, which are used to protect patients from the harmful effects of X-ray dye used during commonly performed angiographic imaging procedures. The company was incorporated in 2005 and is headquartered in Minnetonka, Minnesota.
Q&A For Osprey Medical, Inc. Stock
What is a current OSP.XA stock price?
Osprey Medical, Inc. OSP.XA stock price today per share is 0.45 AUD.
How to purchase Osprey Medical, Inc. stock?
You can buy OSP.XA shares on the CXA exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Osprey Medical, Inc.?
The stock symbol or ticker of Osprey Medical, Inc. is OSP.XA.
How many shares does Osprey Medical, Inc. have in circulation?
The max supply of Osprey Medical, Inc. shares is 0.
What is Osprey Medical, Inc. Price to Earnings Ratio (PE Ratio)?
Osprey Medical, Inc. PE Ratio is 0.00000000 now.
What was Osprey Medical, Inc. earnings per share over the trailing 12 months (TTM)?
Osprey Medical, Inc. EPS is 0 AUD over the trailing 12 months.